# 68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors

> **NCT07331532** · — · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Breast Neoplasms、Lung Neoplasms、Pancreatic Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07331532
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07331532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07331532, "68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07331532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*